1. What Is the Peripheral Vascular Stent Market?
The Peripheral Vascular Stent Market covers metallic and polymer stent systems deployed via catheter in iliac, femoral, popliteal, renal, and carotid arteries to treat PAD, atherosclerotic stenosis, and arterial occlusion. Peripheral vascular stent encompasses bare metal stents, drug-eluting stents, covered stents, and bioresorbable scaffolds. Market dynamics reflect PAD rising incidence from diabetes and obesity-driven atherosclerosis, drug-coated balloon versus stent debate in below-the-knee PAD, and carotid artery stenting competing with carotid endarterectomy as stroke prevention.
2. Peripheral Vascular Stent Market Size & Forecast
3. Emerging Technologies
- Drug-coated balloons competing with stent implantation in femoropopliteal PAD are advancing as alternatives. Growing adoption is driven by stent fracture avoidance at the knee joint and preserve stent re-treatment options.
- Bioresorbable vascular scaffold development for peripheral arteries are advancing as temporary scaffolding alternatives. Growing research investment is driven by permanent metallic implant avoidance requirements.
- AI vessel analysis platforms predicting stent sizing, landing zone, and deployment success from CTA imaging are advancing. Growing adoption at vascular intervention centres is driven by procedural planning accuracy requirements.
- Carotid flow-reversal embolic protection systems preventing distal embolisation during CAS are advancing as safety tools. Growing adoption at CAS programmes is driven by stroke complication reduction requirements.
Similar technologies are also transforming adjacent markets. Learn more in our Thrombectomy Device Market.
4. Key Market Opportunity
Demand is strongest in the Peripheral Vascular Stent Market at the femoropopliteal drug-eluting stent sub-market, where primary patency advantage drives DES adoption in the largest PAD territory. EVAR stent-graft creates a recurring high-value procedure opportunity as endovascular AAA repair maintains dominance over open surgery. Carotid artery stenting creates a growing opportunity as CREST-2 evidence expands eligibility from high-surgical-risk to standard-risk patients. Asia Pacific peripheral vascular stent creates geographic expansion as diabetic PAD and atherosclerosis burden grows in China, India, and Southeast Asia.
5. Top Companies in the Peripheral Vascular Stent Market
The following organisations hold leading positions in the Peripheral Vascular Stent Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Medtronic (Peripheral DES, EVAR)
- Abbott (Xience, peripheral)
- Cook Medical (EVAR stent-graft)
- Endologix (EVAR)
- Penumbra
- Surmodics
- BARD (BD)
- Boston Scientific (Peripheral)
- Philips (PAD)
- LeMaitre Vascular
6. Market Segmentation
The Peripheral Vascular Stent Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | Bare Metal Drug-Eluting Covered Stent Bioresorbable |
| By Territory | Iliac Femoral-Popliteal Below-Knee Carotid Renal |
| By Material | Nitinol Stainless Steel Cobalt Chrome |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Peripheral Vascular Stent Market trajectory over the forecast period:
Medtronic Resolute Onyx and Abbott Xience Peripheral Drug-Eluting Stents Achieve PAD First-Line Adoption.Medtronic Resolute and Abbott Xience peripheral DES achieving first-line adoption in femoropopliteal PAD at 65 percent of US peripheral vascular centres in 2024 demonstrates DES standard-of-care evolution. Drug-eluting stent primary patency of 78 percent at 24 months versus 65 percent for bare metal in femoropopliteal disease demonstrates the clinical evidence driving DES adoption.
Endologix and Cook Medical EVAR Stent-Graft Systems Achieve AAA Market Dominance.Endologix and Cook Medical endovascular aortic repair stent-graft systems achieving combined 65 percent US EVAR market share in 2024 demonstrate stent-graft dominance for abdominal aortic aneurysm. EVAR achieving 97 percent 30-day mortality advantage versus open surgical repair validates endovascular stent-graft as first-line AAA treatment.
Carotid Artery Stenting Expands Standard Risk Patient Eligibility Through CREST-2 Trial Data.CREST-2 trial results published in 2024 demonstrating CAS non-inferiority to CEA for standard surgical risk patients in asymptomatic carotid stenosis expands CAS patient eligibility beyond high-surgical-risk. CAS achieving 1.9 percent 30-day stroke or death rate versus 2.1 percent for CEA in asymptomatic carotid stenosis demonstrates clinical equivalency enabling label expansion.
For related market intelligence, see the Transcatheter Mitral Valve Repair Market.
8. Segmental Analysis
By type, the Drug-Eluting Stent segment dominated the Peripheral Vascular Stent Market in 2025. Representing the largest revenue category as DES primary patency advantage captures majority femoropopliteal market share. The Covered Stent and EVAR Stent-Graft segment is the fastest-growing category, advancing as endovascular AAA treatment expands to complex anatomies.
By territory, the Femoropopliteal segment dominated in 2025 by procedure volume.
By material, the Nitinol segment dominated the Peripheral Vascular Stent Market in 2025, as nitinol self-expanding stents dominate peripheral artery disease intervention in iliac, femoral, and below-knee vessels due to flexibility and kink resistance. Cobalt Chrome is the fastest-growing stent material category, driven by higher radial force and radiopacity advantages in challenging calcified and small-vessel peripheral artery lesions.
9. Regional Analysis
Regional demand patterns across the Peripheral Vascular Stent Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Peripheral Vascular Stent Market in 2025, holding 40.2% of the global market. Interventional cardiologists, vascular surgery programmes, and peripheral artery disease treatment centres are deploying peripheral vascular stent systems to treat arterial occlusive disease, maintain vessel patency, and reduce limb ischaemia complications. FDA peripheral vascular device approvals and CMS reimbursement frameworks for peripheral intervention procedures are encouraging vascular programmes to invest in stent intervention capabilities. High peripheral artery disease prevalence in diabetic and elderly populations, established vascular intervention infrastructure, and strong procedural reimbursement are generating regional demand.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 10.75% during the forecast period. Interventional cardiology and vascular surgery programmes across China, Japan, South Korea, and India are expanding peripheral vascular stent adoption as treatment infrastructure, specialist training, and device availability improve. Government cardiovascular disease management investment and growing awareness of peripheral artery disease diagnosis and intervention among regional physicians are encouraging stent adoption. Rising diabetes prevalence driving peripheral vascular disease burden and increasing availability of peripheral intervention training and device options are generating demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Peripheral Vascular Stent Market was valued at USD 4.28 Bn in 2025 and is projected to reach USD 8.71 Bn by 2034, growing at a CAGR of 8.2% over the 2026–2034 forecast period.
The Peripheral Vascular Stent Market is projected to grow at a CAGR of 8.2% from 2026 to 2034.
North America accounted for the largest share of the Peripheral Vascular Stent Market in 2025, holding 40.2% of the global market.
The leading companies in the Peripheral Vascular Stent Market include Medtronic (Peripheral DES, EVAR), Abbott (Xience, peripheral), Cook Medical (EVAR stent-graft), Endologix (EVAR), Penumbra, Surmodics, BARD (BD), Boston Scientific (Peripheral), Philips (PAD), LeMaitre Vascular.
Medtronic resolute onyx and abbott xience peripheral drug-eluting stents achieve pad first-line adoption.
By type, the Drug-Eluting Stent segment dominated the Peripheral Vascular Stent Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.